InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the full record of transactions filed by Gupta Suneel, Directeur. Insider active across 1 company, notably Protagonist Therapeutics, Inc. Cumulatively, 10 filings have been recorded. History available since 15 February 2022. The latest transaction was disclosed on 25 November 2024 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Gupta Suneel
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报10 总计
45,000 股@ US$7.3835.3% 占其流量Common StockSEC:0001104659-24-123807:0
4,282 股@ US$29.5313.0% 占其流量Common StockSEC:0001104659-24-028886:0
5,000 股@ US$7.383.8% 占其流量Common StockSEC:0001104659-24-003435:0
19,250 股0Common StockSEC:0001104659-24-001495:0
20,000 股@ US$7.3815.5% 占其流量Common StockSEC:0001104659-23-110803:0
12,000 股0Common StockSEC:0001104659-23-067691:0
20,625 股0Common StockSEC:0001104659-23-004730:0
40,000 股@ US$7.3830.9% 占其流量Common StockSEC:0001104659-22-050560:0
649 股@ US$24.281.6% 占其流量Common StockSEC:0001104659-22-029522:0
12,500 股0Common StockSEC:0001104659-22-024838:0
10 条申报中的 10 条
About Gupta Suneel
Gupta Suneel is a Director and Chief Development Officer at Protagonist Therapeutics, Inc. He has 10 filings in total, and in the recent sample covered, the transactions are option exercises between 2022-02-17 and 2024-11-27, with buy and sell amounts shown as EUR 0.
